A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma
Clinical trial NCT07574528 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07574528
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-06
- Primary completion
- 2028-03-06
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.